The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
暂无分享,去创建一个
Kristian Thorlund | David Moher | Chris Cameron | John Ioannidis | Isabelle Boutron | Anna Chaimani | Georgia Salanti | Brian Hutton | Kay Dickersin | Deborah Caldwell | Sharon Straus | J. Ioannidis | J. Jansen | D. Moher | K. Dickersin | I. Boutron | C. Mulrow | D. Altman | S. Straus | P. Gtzsche | G. Salanti | A. Chaimani | K. Thorlund | B. Hutton | D. Caldwell | C. Cameron | C. Schmid | Ferrn Catal-Lpez | Christopher Schmid | Jeroen Jansen | Cynthia Mulrow | Ferrn Catal-Lpez | Peter Gtzsche | Douglas Altman | Peter C. Gtzsche | Peter Gtzsche
[1] Nicky J Welton,et al. Linear inference for mixed treatment comparison meta‐analysis: a two‐stage approach , 2012, Research Synthesis Methods.
[2] S Dias,et al. Checking consistency in mixed treatment comparison meta‐analysis , 2010, Statistics in medicine.
[3] John Ioannidis,et al. Exploring the Geometry of Treatment Networks , 2008, Annals of Internal Medicine.
[4] N. Welton,et al. Addressing between‐study heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments in individuals with non‐rheumatic atrial fibrillation , 2009, Statistics in medicine.
[5] Chris Cameron,et al. Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis , 2013, BMJ.
[6] Ian R. White,et al. Multivariate Random-effects Meta-analysis , 2009 .
[7] Carl Heneghan,et al. What is missing from descriptions of treatment in trials and reviews? , 2008, BMJ : British Medical Journal.
[8] Anna Chaimani,et al. Evaluating the Quality of Evidence from a Network Meta-Analysis , 2014, PloS one.
[9] David C Hoaglin,et al. Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2. , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[10] J. Ioannidis,et al. Network geometry shows evidence sequestration for medical vs. surgical practices: treatments for basal cell carcinoma. , 2014, Journal of clinical epidemiology.
[11] Guobing Lu,et al. Modeling between-trial variance structure in mixed treatment comparisons. , 2009, Biostatistics.
[12] Kristian Thorlund,et al. Stability of additive treatment effects in multiple treatment comparison meta-analysis: a simulation study , 2012, Clinical epidemiology.
[13] Dimitris Mavridis,et al. Network meta‐analysis models to account for variability in treatment definitions: application to dose effects , 2013, Statistics in medicine.
[14] D. Spiegelhalter,et al. Disease Mapping With WinBUGS and MLwiN, Bayesian Approaches to Clinical Trials and Health Care Evaluation , 2004 .
[15] Iveta Simera,et al. Describing reporting guidelines for health research: a systematic review. , 2011, Journal of clinical epidemiology.
[16] Kristian Thorlund,et al. The effects of excluding treatments from network meta-analyses: survey , 2013, BMJ : British Medical Journal.
[17] T. Stijnen,et al. Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis , 2013, BMJ : British Medical Journal.
[18] C. Bias. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials , 2011 .
[19] David Moher,et al. PRISMA-Equity 2012 Extension: Reporting Guidelines for Systematic Reviews with a Focus on Health Equity , 2012, PLoS medicine.
[20] Philippe Ravaud,et al. Adjustment for reporting bias in network meta-analysis of antidepressant trials , 2012, BMC Medical Research Methodology.
[21] Neil Hawkins,et al. Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: A tutorial , 2010, BMC medical research methodology.
[22] J. Ioannidis,et al. Biologic agents in rheumatology: unmet issues after 200 trials and $200 billion sales , 2013, Nature Reviews Rheumatology.
[23] Georgia Salanti,et al. Indirect and mixed‐treatment comparison, network, or multiple‐treatments meta‐analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool , 2012, Research synthesis methods.
[24] Joseph C Cappelleri,et al. Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1. , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[25] D. Moher,et al. A catalogue of reporting guidelines for health research , 2010, European journal of clinical investigation.
[26] Youping Li,et al. The reporting quality of meta-analyses improves: a random sampling study. , 2008, Journal of clinical epidemiology.
[27] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.
[28] Peter C Gøtzsche,et al. Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review , 2006, BMJ : British Medical Journal.
[29] John P A Ioannidis,et al. Neglected tropical diseases: survey and geometry of randomised evidence , 2012, BMJ : British Medical Journal.
[30] D. Coyle,et al. Systematic review and network meta-analysis comparing antithrombotic agents for the prevention of stroke and major bleeding in patients with atrial fibrillation , 2014, BMJ Open.
[31] David Moher,et al. Epidemiology and Reporting Characteristics of Systematic Reviews , 2007, PLoS medicine.
[32] Panagiota Spyridonos,et al. Graphical Tools for Network Meta-Analysis in STATA , 2013, PloS one.
[33] Sofia Dias,et al. Extending methods for investigating the relationship between treatment effect and baseline risk from pairwise meta‐analysis to network meta‐analysis , 2013, Statistics in medicine.
[34] Alex J. Sutton,et al. Evidence Synthesis for Decision Making 2 , 2013, Medical decision making : an international journal of the Society for Medical Decision Making.
[35] Deborah M Caldwell,et al. Mixed treatment comparison analysis provides internally coherent treatment effect estimates based on overviews of reviews and can reveal inconsistency. , 2010, Journal of clinical epidemiology.
[36] J. Ioannidis,et al. Industry sponsorship and selection of comparators in randomized clinical trials , 2010, European journal of clinical investigation.
[37] David Moher,et al. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. , 2012, The Cochrane database of systematic reviews.
[38] Alex J. Sutton,et al. Heterogeneity: Subgroups, Meta-Regression, Bias And Bias-Adjustment , 2011 .
[39] Deborah M Caldwell,et al. Novel presentational approaches were developed for reporting network meta-analysis. , 2014, Journal of clinical epidemiology.
[40] Nicky J Welton,et al. Evaluating novel agent effects in multiple‐treatments meta‐regression , 2010, Statistics in medicine.
[41] Christopher H. Schmid,et al. Characteristics of Networks of Interventions: A Description of a Database of 186 Published Networks , 2014, PloS one.
[42] J. Ioannidis,et al. Homophily and co-occurrence patterns shape randomized trials agendas: illustration in antifungal agents. , 2011, Journal of clinical epidemiology.
[43] Catrin Tudur Smith,et al. Assessing the consistency assumption by exploring treatment by covariate interactions in mixed treatment comparison meta‐analysis: individual patient‐level covariates versus aggregate trial‐level covariates , 2012, Statistics in medicine.
[44] Nicky J Welton,et al. How valuable are multiple treatment comparison methods in evidence-based health-care evaluation? , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[45] Kristian Thorlund,et al. How to use an article reporting a multiple treatment comparison meta-analysis. , 2012, JAMA.
[46] Andrea Cipriani,et al. Conceptual and Technical Challenges in Network Meta-analysis , 2013, Annals of Internal Medicine.
[47] Ian R. White,et al. Multivariate Random-effects Meta-regression: Updates to Mvmeta , 2011 .
[48] Andrew W Lee,et al. Review of mixed treatment comparisons in published systematic reviews shows marked increase since 2009. , 2014, Journal of clinical epidemiology.
[49] Wei-Chih Liao,et al. Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis. , 2013, The Lancet. Oncology.
[50] Alex J. Sutton,et al. Evidence Synthesis for Decision Making 4 , 2013, Medical decision making : an international journal of the Society for Medical Decision Making.
[51] Dan Jackson,et al. A design-by-treatment interaction model for network meta-analysis with random inconsistency effects , 2014, Statistics in medicine.
[52] Douglas G Altman,et al. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses , 2003, BMJ : British Medical Journal.
[53] G. Lu,et al. Combination of direct and indirect evidence in mixed treatment comparisons , 2004, Statistics in medicine.
[54] Byron Jones,et al. Statistical approaches for conducting network meta‐analysis in drug development , 2011, Pharmaceutical statistics.
[55] Nicky J Welton,et al. Estimation and adjustment of bias in randomized evidence by using mixed treatment comparison meta‐analysis , 2010 .
[56] Tommi Tervonen,et al. Algorithmic parameterization of mixed treatment comparisons , 2011, Statistics and Computing.
[57] J. Ioannidis,et al. A test for reporting bias in trial networks: simulation and case studies , 2014, BMC Medical Research Methodology.
[58] Gerta Rücker,et al. Network meta‐analysis, electrical networks and graph theory , 2012, Research synthesis methods.
[59] Joseph C Cappelleri,et al. Indirect treatment comparison/network meta-analysis study questionnaire to assess relevance and credibility to inform health care decision making: an ISPOR-AMCP-NPC Good Practice Task Force report. , 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[60] AE Ades,et al. Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies‡ , 2012, Research synthesis methods.
[61] Bradley P. Carlin,et al. Bayesian measures of model complexity and fit , 2002 .
[62] J. Ioannidis,et al. The need to consider the wider agenda in systematic reviews and meta-analyses: breadth, timing, and depth of the evidence , 2010, BMJ : British Medical Journal.
[63] G. Lu,et al. Assessing Evidence Inconsistency in Mixed Treatment Comparisons , 2006 .
[64] Nicky J Welton,et al. Automating network meta‐analysis , 2012, Research synthesis methods.
[65] Georgia Salanti,et al. Multiple-treatments meta-analysis of chemotherapy and targeted therapies in advanced breast cancer. , 2008, Journal of the National Cancer Institute.
[66] Kristian Thorlund,et al. Modelling heterogeneity variances in multiple treatment comparison meta-analysis – Are informative priors the better solution? , 2013, BMC Medical Research Methodology.
[67] A. Owen,et al. Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomised controlled trials , 2007, BMJ : British Medical Journal.
[68] Julian P T Higgins,et al. Evaluation of inconsistency in networks of interventions. , 2013, International journal of epidemiology.
[69] C. Di Pietrantonj,et al. Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis. , 2013, The Cochrane database of systematic reviews.
[70] Georgia Salanti,et al. Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. , 2011, Journal of clinical epidemiology.
[71] G. Guyatt,et al. Fluid Resuscitation in Sepsis , 2014, Annals of Internal Medicine.
[72] D M Caldwell,et al. Waiting list may be a nocebo condition in psychotherapy trials: a contribution from network meta‐analysis , 2014, Acta psychiatrica Scandinavica.
[73] Harald Binder,et al. A graphical tool for locating inconsistency in network meta-analyses , 2013, BMC Medical Research Methodology.
[74] David B. Dunson,et al. Bayesian Data Analysis , 2010 .
[75] D. Moher,et al. Guidance for Developers of Health Research Reporting Guidelines , 2010, PLoS medicine.
[76] Shannon Cope,et al. Meta-regression models to address heterogeneity and inconsistency in network meta-analysis of survival outcomes , 2012, BMC Medical Research Methodology.
[77] Kristian Thorlund,et al. The Quality of Reporting Methods and Results in Network Meta-Analyses: An Overview of Reviews and Suggestions for Improvement , 2014, PloS one.
[78] P. Kolh,et al. Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis , 2014, BMJ : British Medical Journal.
[79] Deborah M Caldwell,et al. Validity of indirect comparisons in meta-analysis , 2007, The Lancet.
[80] Jeroen P Jansen,et al. Network meta‐analysis of individual and aggregate level data , 2012, Research synthesis methods.
[81] J. Ioannidis,et al. Geometry of the randomized evidence for treatments of pulmonary hypertension. , 2013, Cardiovascular therapeutics.
[82] Georgia Salanti,et al. Evaluation of networks of randomized trials , 2008, Statistical methods in medical research.
[83] S D Walter,et al. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. , 1997, Journal of clinical epidemiology.
[84] Mohammad Hassan Murad,et al. A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis , 2014, BMJ : British Medical Journal.
[85] Nicky J Welton,et al. Network meta-analysis with competing risk outcomes. , 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[86] A Network Meta-Analysis on Randomized Trials Focusing on the Preventive Effect of Statins on Contrast-Induced Nephropathy , 2014, BioMed research international.
[87] Julian P T Higgins,et al. A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered. , 2009, Journal of clinical epidemiology.
[88] Kristian Thorlund,et al. Multiple treatment comparison meta-analyses: a step forward into complexity , 2011, Clinical epidemiology.
[89] Gerben ter Riet,et al. Comparative effectiveness of long term drug treatment strategies to prevent asthma exacerbations: network meta-analysis , 2014, BMJ : British Medical Journal.
[90] Deborah M Caldwell,et al. Selecting the best scale for measuring treatment effect in a network meta‐analysis: a case study in childhood nocturnal enuresis , 2012, Research synthesis methods.
[91] I. Olkin,et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement , 1999, The Lancet.
[92] John P.A. Ioannidis,et al. Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses , 2009, Canadian Medical Association Journal.
[93] J. Sterne,et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.
[94] Anna Chaimani,et al. Using network meta‐analysis to evaluate the existence of small‐study effects in a network of interventions , 2012, Research synthesis methods.
[95] Nicky J Welton,et al. A selection model for accounting for publication bias in a full network meta‐analysis , 2014, Statistics in medicine.
[96] D. Moher,et al. CONSORT for Reporting Randomized Controlled Trials in Journal and Conference Abstracts: Explanation and Elaboration , 2008, PLoS medicine.
[97] Simon G Thompson,et al. Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews , 2012, International journal of epidemiology.
[98] Deborah M Caldwell,et al. Simultaneous comparison of multiple treatments: combining direct and indirect evidence , 2005, BMJ : British Medical Journal.
[99] Walter Ricciardi,et al. Evaluation of the Endorsement of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) Statement on the Quality of Published Systematic Review and Meta-Analyses , 2013, PloS one.
[100] Kristian Thorlund,et al. Sample size and power considerations in network meta-analysis , 2012, Systematic Reviews.
[101] Keith Abrams,et al. Use of Indirect and Mixed Treatment Comparisons for Technology Assessment , 2012, PharmacoEconomics.
[102] John P. A. Ioannidis,et al. Undue industry influences that distort healthcare research, strategy, expenditure and practice: a review , 2013, European journal of clinical investigation.
[103] J. Ioannidis,et al. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, Annals of Internal Medicine [serial online].
[104] R. Rosenthal,et al. Selective publication of antidepressant trials and its influence on apparent efficacy. , 2008, The New England journal of medicine.
[105] Dimitris Mavridis,et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis , 2013, The Lancet.
[106] M. Pfisterer,et al. Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis , 2008, BMJ : British Medical Journal.